Business Wire

Forecasting, Monitoring and KI – Swarm Intelligence for the Energy Transition at EM-Power Europe

Share

The energy transition does not just change the energy generation technologies we use, but also requires the power grids to be updated. Today, instead of a dozen large-scale power plants, an enormous swarm of power plants all feed into our grid: Several thousand wind farms and over 2.6 million PV systems have been installed in Germany alone – and there is a steep upward trend. This makes our power generation weather dependent: On windless or cloudy days, the energy supply may not match the demand, leading to bottlenecks – or worse – blackouts. To keep the grid frequency at a stable 50.2 hertz, grid operators need yield forecasts. Artificial intelligence (AI) helps process this highly complex information and integrate it into the energy system.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230601005572/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

EM-Power Europe Exhibition (Photo: Solar Promotion GmbH)

With millions of solar installations, wallboxes and heat pumps, home storage systems and car batteries that will someday be able to feed electricity back into the grid, today’s utility grid system is already so complex that utilities and grid operators would be lost without their digitalized systems. The more they know about when, where and how much electricity is being produced, fed into the grid and demanded by consumers, the more precisely can they match their supply to the demand. This also makes it more profitable, as making up for shortages is expensive. When generation does not cover consumption within a balancing group, grid operators are forced to pay balancing costs. The more accurate the weather and yield forecasts for wind and solar power plants, the more successful the companies will be. Individuals who want to optimize their self-consumption using batteries or controllable consumers like e-cars or heat pumps also require forecasts to determine what the electricity should be used for. The same goes for the energy management of buildings.

Weather forecast for the energy industry

At EM-Power Europe, the international exhibition for energy management and integrated energy solutions, companies from all around the world present their digitalization concepts as well as innovative technologies and services for the optimized grid of the future. “Machine learning and AI play a crucial role in the irradiation forecast,” Jan Remund, Head of the Department for Energy and Climate at Meteotest AG, a Swiss weather forecast provider, explains. The company is able to predict cloud movements by combining physical models with self-learning algorithms based on satellite images. “The accuracy for the next few hours is quite high. The longer the time span, the less accurate the forecasts are,” says Remund. His company collects irradiation and temperature data and uses it to make analyses, profiles and forecasts that can be integrated into the respective PV monitoring or control software. Companies can use the weather forecasts as a basis for calculating solar irradiation using dedicated software, or they can buy such calculations. Grid operators rely on irradiation forecasts to balance the grid’s feed-in and feed-out based on the production and demand forecasts.

Meteocontrol, a monitoring and forecast specialist company from the South of Germany makes yield calculations based on the data of different weather forecast providers. The company also investigates how aerosols like ash or sand affect cloud formation. “On March 3 and 4, 2021, our research project “PermaStrom” exemplified how important this issue is,” says Stijn Stevens, CEO of meteocontrol. “There was a lot of Saharan dust in Europe on those two days. Thanks to optimized forecasts, about three million euros were saved in balancing energy costs in Germany alone.

The integration of smart applications and AI into the utility grid system creates digital swarm intelligence. By combining the power generation and consumption forecasts with the capacity of conventional power plants, grid operators can predict when and where the grids and transformers will reach their maximum capacity. This allows them to take the necessary precautions.

Prosumers: underestimated key players

Prosumers will play a vital role in the energy systems of the future: For instance, private individuals and households can feed excess electricity from their e-cars into the grid, contributing significantly to its stability. The company Hive Power already offers software for the intermittent feedback of electricity from car batteries into the grid, called Vehicle-to-Grid. Artificial intelligence helps here, too: The software learns when vehicles are in use and when they are not, allowing it to feed electricity into the grid when there is excess capacity. Prosumers could earn up to 1,000 euros per year in this way.

Smart technology for buildings

Weather and yield forecasts are also crucial for the energy management of buildings. Heat pumps can charge the heating storage device when the sun is shining, and feed the energy into the heating circuit in the evening. With the right software, heat pumps can apply the yield forecasts provided by the energy management system to their operating schedules. This prevents heat pumps from using grid-supplied electricity to heat thermal energy storage when sufficient solar energy is expected within the next hour. Another possibility is to time the charging of electric vehicles in a way that maximizes the share of solar power. Solar-Log’s systems are based on the same principle. They provide optimal electricity self-consumption for office buildings and industrial facilities through battery storage and flexible loads, such as heat pumps or charging stations.

Apart from the aforementioned companies, numerous other exhibitors will present their solutions for weather and yield forecasts, grid connection, monitoring and analysis software at EM-Power Europe in Munich from June 14–16. Visitors can learn more about the possibilities of forecasting and monitoring systems at the EM-Power Forum session “Forecasting & monitoring: Always a step ahead” (“Forecasting & Monitoring: Immer einen Schritt voraus sein”).

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press Contacts

Peggy Zilay
Spokesperson
The smarter E Europe
+49 7231 58598-240
zilay@solarpromotion.com

Juliane Heermeier
Account Manager
+49 151 41482446
juliane.heermeier@fischerappelt.de

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 11:00:00 EET | Press release

Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeking future-ready solutions. At the core of this strategy is Regnology Risk Hub (RRiskHub), an integrated solution designed to deliver a single

Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 11:00:00 EET | Press release

Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 10:00:00 EET | Press release

Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at week 16, with a significantly greater PASI 75 response rate seen as early as week 4 and continuing to increase through week 24. The studies also met all 44 ranked secondary endpoints, including PASI 90, PASI 100 and sPGA 0 against placebo and apremilast, showing the potential of a convenient once-daily pill to deliver complete skin clearance for patients with PsO. “People living with psoriasis continue to seek safe, effective and fast-acting oral therap

DATROWAY ® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 09:30:00 EET | Press release

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use. The application is based on data from the TROPION-Breast02 phase 3 trial presented in a late-breaking proffered paper session at the 2025 European Society for Medical Oncology (#ESMO25) Congress. In the trial, DATROWAY demonstrated statistically significant and clinical

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 04:41:00 EET | Press release

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution for intravenous infusion. “The new SteQeyma™ autoinjector brings together convenience and practical usability to meet the everyday challenges faced by patients living with chronic inflammatory diseases. The full range of our SteQeyma™ dosage forms and strengths, with the autoinjector now added, provides patients and healthcare professionals with more individualized treatm

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye